About AudioScholar Allergy & Immunology Weekly (India)
Allergy & Immunology — a weekly podcast briefing of the most significant peer-reviewed allergy & immunology literature, synthesized from PubMed and delivered as ~10-minute audio. For practicing physicians. Generated by AudioScholar at audioscholar.cc. India edition.
Editor's Pick: European Guidelines on Eosinophilic Esophagitis: Evidence-Based Statements and Recommendations for Diagnosis and Management in Children and Adults. Part 1: Diagnosis, Epidemiology and Natural History (Allergy, 2026)
This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice.
Welcome to This Week in Allergy & Immunology. This week we're covering 10 notable papers spanning eosinophilic gastrointestinal disease, biologic therapy and steroid safety in the airways, and the practical realities of food allergy and immune defici…
This week's papers:
1. European Guidelines on Eosinophilic Esophagitis: Evidence-Based Statements and Recommendations for Diagnosis and Management in Children and Adults. Part 1: Dia… — Allergy 2026
2. Precision Diagnosis and Differentiation of Eosinophilic Colitis and Inflammatory Bowel Disease Using a Tissue-Based Molecular Gene Expression Panel. — Journal of Allergy and Clinical Immunology 2026
3. Increased Exacerbation Reduction Over Time with Tezepelumab in Severe Asthma: CROSSROADS-4. — The Journal of Allergy and Clinical Immunology: In Practice 2026
4. Three-year real-world effectiveness of dupilumab in eosinophilic CRSwNP across upper and lower airways. — Allergology International 2026
5. Systemic Corticosteroid and Tendino-Myopathy Risk in Pediatric Asthma: A Self-Controlled Case Series. — The Journal of Allergy and Clinical Immunology: In Practice 2026
6. Diagnostic performance and clinical utility of open oral food challenges using double-blind, placebo-controlled food challenges as the reference standard: A sy… — Allergology International 2026
7. The Spectrum of FPIES severity: A Cohort Analysis of Fully and Partially Met Diagnostic Criteria. — The Journal of Allergy and Clinical Immunology: In Practice 2026
8. Do School Food Allergy Policies Harm or Help? Quality of Life, Anxiety, and Bullying in Children with Peanut and Tree Nut Allergy. — Journal of Allergy and Clinical Immunology 2026
9. Pre-Rituximab Immunoglobulin Testing and Baseline Hypogammaglobulinemia Across Rituximab Indications in Adults: A Multisite Retrospective Study. — The Journal of Allergy and Clinical Immunology: In Practice 2026
10. Demystifying Genetic Workup of Inborn Errors of Immunity. — Current Allergy and Asthma Reports 2026
Listen at https://audioscholar.cc/episode/6522f4es2w
26 Oct 2026
This Week in Allergy & Immunology — Oct 25, 2026
Editor's Pick: Rituximab vs Azathioprine for Eosinophilic Granulomatosis With Polyangiitis Maintenance Therapy: A Randomized Clinical Trial (JAMA, 2026)
This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice.
Welcome to This Week in Allergy & Immunology. This week we're covering 10 notable papers spanning type 2 biologics across the airway, skin, gut and vasculature, anaphylaxis and drug provocation testing, and two rarer corners of the specialty, aspleni…
This week's papers:
1. Comparative efficacy and safety of treatments for eosinophilic esophagitis: Systematic review and network meta-analysis of randomized controlled trials. — Journal of Allergy and Clinical Immunology 2026
2. Total IgE Levels Better Predict Atopic Dermatitis Flares Than Disease Severity, and Both Are Reduced by Dupilumab Treatment. — The Journal of Allergy and Clinical Immunology: In Practice 2026
3. Personalised dupilumab therapy in severe asthma: real-world dosing interval prolongation among early responders. — The Journal of Allergy and Clinical Immunology: In Practice 2026
4. Mepolizumab reduces oral corticosteroid use across distinct severe asthma phenotypes: 2-year REALITI-A study. — The Journal of Allergy and Clinical Immunology: In Practice 2026
5. Rituximab vs Azathioprine for Eosinophilic Granulomatosis With Polyangiitis Maintenance Therapy: A Randomized Clinical Trial. — JAMA 2026
6. Cofactors in Anaphylaxis: Insights From the European Anaphylaxis Registry. — Clinical and Experimental Allergy 2026
7. Cumulative 600-mg Aspirin Oral Provocation Testing in Skin-Predominant NSAID Hypersensitivity: A Retrospective Cohort Study. — Annals of Allergy, Asthma & Immunology 2026
8. The Cost-Effectiveness of Requiring Universal and Indefinite Epinephrine Prescriptions for All Patients Receiving Omalizumab to Prevent Anaphylaxis Fatality. — The Journal of Allergy and Clinical Immunology: In Practice 2026
9. A Link Between Immunoglobulin M Levels and Overwhelming Post-Splenectomy Infection Risk in a National Asplenia Cohort. — The Journal of Allergy and Clinical Immunology: In Practice 2026
10. Long-term prophylaxis for hereditary angioedema: Navigating the switch between therapies. — World Allergy Organization Journal 2026
Listen at https://audioscholar.cc/episode/pckuqpvgh9
19 Oct 2026
This Week in Allergy & Immunology — Oct 18, 2026
This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice.
Welcome to This Week in Allergy & Immunology. This week we're covering 10 notable papers spanning chronic urticar…
This week's papers:
1. Comparative efficacy and safety of antihistamines, increased antihistamine dosing, and antihistamine adjuncts for chronic urticaria: a systematic review, dose-… — Journal of Allergy and Clinical Immunology 2026
2. Relapse Rates, Time-to-Flare, and Biomarker Predictors Following Omalizumab Gradual De-escalation versus Abrupt Discontinuation in Controlled Chronic Spontaneo… — International Archives of Allergy and Immunology 2026
3. Second-line dupilumab after anti-IL5/Rα failure: remission rates and clinical outcomes in severe asthma. — The Journal of Allergy and Clinical Immunology: In Practice 2026
4. Hereditary α-tryptasemia is associated with response to omalizumab in severe allergic asthma. — Annals of Allergy, Asthma & Immunology 2026
5. Efficacy and Safety of Sublingual versus Subcutaneous Immunotherapy for Patients with Allergic Rhinitis with Asthma: A Systematic Review and Meta-analysis. — International Archives of Allergy and Immunology 2026
6. A Systematic Review and Meta-Analysis of Temporal Trends in United States' Pediatric Food Allergy. — Annals of Allergy, Asthma & Immunology 2026
7. International survey of parental and patient perspectives on emerging adrenaline devices for community-based management of anaphylaxis: An EAACI task force rep… — Pediatric Allergy and Immunology 2026
8. Pediatric Alpha-Gal Syndrome: From Missed Diagnosis to the Burden of Avoidance. — Annals of Allergy, Asthma & Immunology 2026
9. Systemic Allergic Reactions to mRNA COVID-19 Vaccines: A Randomized Placebo-controlled Trial. — Journal of Allergy and Clinical Immunology 2026
10. Delayed Drug Hypersensitivity: Mechanistic Advances and Emerging Therapies. — Current Allergy and Asthma Reports 2026
Listen at https://audioscholar.cc/episode/vtv4uck9fz
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
